{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T01:44:39Z","timestamp":1772847879642,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.ahj.2005.08.023","type":"journal-article","created":{"date-parts":[[2006,8,11]],"date-time":"2006-08-11T07:08:58Z","timestamp":1155280138000},"page":"263-269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["A pharmacoepidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention"],"prefix":"10.1016","volume":"152","author":[{"given":"James M.","family":"Brophy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohan N.","family":"Babapulle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vania","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephane","family":"Rinfret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2005.08.023_bib1","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM199610243351707","article-title":"Advances in coronary angioplasty","volume":"335","author":"Bittl","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.08.023_bib2","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(99)00005-3","article-title":"Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin","volume":"83","author":"Wilson","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.08.023_bib3","first-page":"460","article-title":"Timing of coronary stent thrombosis in patients treated with prophylactic tirofiban","volume":"12","author":"Assali","year":"2000","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.ahj.2005.08.023_bib4","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM199604253341702","article-title":"A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents","volume":"334","author":"Schomig","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.08.023_bib5","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators","volume":"339","author":"Leon","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.08.023_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0735-1097(01)01713-2","article-title":"Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting","volume":"39","author":"Bhatt","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2005.08.023_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/dmd.31.1.53","article-title":"The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin","volume":"31","author":"Clarke","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ahj.2005.08.023_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.CIR.0000047060.60595.CC","article-title":"Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction","volume":"107","author":"Lau","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.08.023_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/01.CIR.0000112378.09325.F9","article-title":"Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance","volume":"109","author":"Lau","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.08.023_bib10","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/S0195-668X(03)00442-1","article-title":"Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function\u2014a flow cytometry study","volume":"24","author":"Neubauer","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2005.08.023_bib11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/01.CIR.0000088780.57432.43","article-title":"Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial","volume":"108","author":"Saw","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.08.023_bib12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0002-9149(03)00626-X","article-title":"Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies","volume":"92","author":"Wienbergen","year":"2003","journal-title":"Am J Cardiol"},{"issue":"Suppl A","key":"10.1016\/j.ahj.2005.08.023_bib13","first-page":"231A","article-title":"Does the use of atorvastatin with clopidogrel increase clinical adverse events after percutaneous coronary intervention?","volume":"19","author":"Wahab","year":"2003","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ahj.2005.08.023_bib14","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1161\/01.CIR.0000124581.18191.15","article-title":"Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes","volume":"109","author":"Mitsios","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.08.023_bib15","first-page":"1","article-title":"Revascularization techniques used in the treatment of stable angina pectoris","author":"Conseil d'evaluation des technologies de la sante","year":"1996"},{"key":"10.1016\/j.ahj.2005.08.023_bib16","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0895-4356(94)00234-H","article-title":"The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec","volume":"48","author":"Tamblyn","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ahj.2005.08.023_bib17","first-page":"1","article-title":"The benefit of cholesterol lowering medications following coronary revascularization. A population study","volume":"149","author":"Brophy","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2005.08.023_bib18","series-title":"Basic and clinical pharmacology","first-page":"51","article-title":"Drug biotransformation","author":"Correia","year":"2001"},{"key":"10.1016\/j.ahj.2005.08.023_bib19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev.pharmtox.38.1.389","article-title":"In vitro and in vivo drug interactions involving human CYP3A","volume":"38","author":"Thummel","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.ahj.2005.08.023_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1567-5688(02)00002-8","article-title":"Pharmacological interactions of statins","volume":"3","author":"Paoletti","year":"2002","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.ahj.2005.08.023_bib21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.ahj.2005.08.023_bib22","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/01.ATV.19.8.2007","article-title":"Specific impairment of human platelet P2Y(AC) ADP receptor\u2013mediated signaling by the antiplatelet drug clopidogrel","volume":"19","author":"Geiger","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ahj.2005.08.023_bib23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s002280100329","article-title":"Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A\u2013reductase inhibitors (statins)","volume":"57","author":"Igel","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ahj.2005.08.023_bib24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0163-7258(99)00045-5","article-title":"New insights into the pharmacodynamic and pharmacokinetic properties of statins","volume":"84","author":"Corsini","year":"1999","journal-title":"Pharmacol Ther"},{"issue":"23 Suppl 1","key":"10.1016\/j.ahj.2005.08.023_bib25","first-page":"III50","article-title":"Safety of statins: focus on clinical pharmacokinetics and drug interactions","volume":"109","author":"Bellosta","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.08.023_bib26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/bdd.249","article-title":"Equally potent inhibitors of cholesterol synthesis in human hepatocytes have distinguishable effects on different cytochrome P450 enzymes","volume":"21","author":"Cohen","year":"2000","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.ahj.2005.08.023_bib27","first-page":"282","article-title":"A comparison of the effects of 3-hydroxy-3-methylglutaryl\u2013coenzyme A (HMG-CoA) reductase inhibitors on the CYP3A4-dependent oxidation of mexazolam in vitro","volume":"29","author":"Ishigami","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ahj.2005.08.023_bib28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0021-9150(01)00606-2","article-title":"Statins do not affect platelet inhibition with clopidogrel during coronary stenting","volume":"159","author":"Serebruany","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2005.08.023_bib29","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1001\/archinte.164.18.2051","article-title":"Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study","volume":"164","author":"Serebruany","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2005.08.023_bib30","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1161\/01.CIR.0000099507.32936.C0","article-title":"Effects of statins on platelet inhibition by a high loading dose of clopidogrel","volume":"108","author":"Muller","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.08.023_bib31","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.ehj.2003.10.039","article-title":"Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting","volume":"25","author":"Gorchakova","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2005.08.023_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/01.CIR.93.2.215","article-title":"A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation","volume":"93","author":"Hall","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.08.023_bib33","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/01.CIR.95.5.1145","article-title":"Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Comparison of aspirin alone versus combined ticlopidine and aspirin therapy","volume":"95","author":"Albiero","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.08.023_bib34","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.08.023_bib35","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1023\/A:1011036428972","article-title":"HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein","volume":"18","author":"Wang","year":"2001","journal-title":"Pharm Res"},{"key":"10.1016\/j.ahj.2005.08.023_bib36","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/sj.bjp.0703920","article-title":"HMG-CoA reductase inhibitors and P-glycoprotein modulation","volume":"132","author":"Bogman","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ahj.2005.08.023_bib37","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1211\/0022357021778493","article-title":"Simvastatin and lovastatin, but not pravastatin, interact with MDR1","volume":"54","author":"Sakaeda","year":"2002","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.ahj.2005.08.023_bib38","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/sim.4780020222","article-title":"The need for randomization in the study of intended effects","volume":"2","author":"Miettinen","year":"1983","journal-title":"Stat Med"},{"key":"10.1016\/j.ahj.2005.08.023_bib39","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/01.CIR.0000127578.21885.3E","article-title":"Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults","volume":"109","author":"Solomon","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.08.023_bib40","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(02)11131-7","article-title":"COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease","volume":"360","author":"Ray","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2005.08.023_bib41","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.08.023_bib42","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(04)17275-9","article-title":"Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy","volume":"364","author":"McFadden","year":"2004","journal-title":"Lancet"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870306000500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870306000500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:28:27Z","timestamp":1757568507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870306000500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0002870306000500"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2005.08.023","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pharmacoepidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2005.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}